Drug diversion programs are strained as hospitals have to reallocate resources to fight against COVID-19. As a result, the global pandemic has exacerbated issues like drug diversion.
One of the most prominent outlets of controlled substance diversion is drug-wasting events. Verifying wasted drugs by analyzing their composition in a lab is slow and not practical in most situations. PharmID detects and prevents diversion quickly with its flagship product, WasteWitness™.
PharmID solutions are powered by Raman Spectroscopy, a technology that analyzes medication via laser to provide drug and concentration verification rapidly. The pass or fail results are delivered to administrators through the powerful, sophisticated web platform.
Health care systems now have the power of the first true molecular verification of medication within seconds. Pharmacists no longer have to rely on a fallible system. Bottom line, WasteWitness verifies that controlled substance waste is what it is supposed to be.
PharmID is the only solution on the market that provides accurate verification of the medication and concentration in pharmaceutical products within seconds. Our solution reduces cost, minimizes risk, improves patient safety and streamlines the preparation process
Marti Jones brings more than 20 years of integrated communications experience from world-renowned organizations. Marti’s career has grown from raising awareness and funds for the American Red Cross before and after 9/11 to leading strategy for brands such as Mayo Clinic, Duke Health, and M Health Fairview, which included communications for change management and COVID-19. Marti's messaging portfolios are supported by her academic background and proven methodology, as she taught writing at the University of Minnesota and honed her craft at UnitedHealth, UCare, and RXinsider, Revel Health and Hill and Knowlton. Marti received her master’s degree in public affairs and administration from George Washington University and Bachelor of Arts degrees in communications and psychology from Augustana University.
This post is related to:
Drug Diversion Monitoring, Diversion Prevention
